Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yeshwanth Vedire

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Thoracic Disease|June 16, 2023
Obesity and lung cancer-a narrative reviewYeshwanth Vedire, Sukumar Kalvapudi, Sai Yendamuri
Frontiers in Oncology|December 25, 2023
Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challengesSukumar Kalvapudi, Yeshwanth Vedire, Sai Yendamuri, et al.
Healthcare (Basel, Switzerland)|March 11, 2023
Geographical Disparities in Esophageal Cancer Incidence and Mortality in the United StatesYeshwanth Vedire, Navpreet Rana, Adrienne Groman, et al.
BMC Cancer|August 19, 2023
Skeletal muscle index is associated with long term outcomes after lobectomy for non-small cell lung cancerYeshwanth Vedire, Lindsay Nitsche, Madeline Tiadjeri, et al.
Cancers|July 27, 2022
Visceral Obesity in Non-Small Cell Lung CancerLindsay Nitsche, Yeshwanth Vedire, Eric Kannisto, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 17, 2024
Sex-based differences in the lung immune microenvironment are associated with an increased risk of lung cancer in womenRandall Smith, Kaylan N Gee, Sukumar Kalvapudi, et al.
Annals of Thoracic Surgery Short Reports|December 17, 2024
Sex-Specific Effects of Body Composition on Tumor Microenvironment in Non-Small Cell Lung Cancer: Obesity, Gender, and TME in NSCLCYeshwanth Vedire, Robert Seager, Erik Van Roey, et al.
ERJ Open Research|June 21, 2023
Immunoprofiling bronchoalveolar lavage cells reveals multifaceted smoking-associated immune dysfunctionRandall Smith, Sai Yendamuri, Yeshwanth Vedire, et al.
JCI Insight|August 26, 2025
Glucagon-like peptide-1 receptor agonism improves lung cancer outcomes and tumor growth controlAkhil Goud Pachimatla, Bailey Fitzgerald, Joyce Ogidigo, et al.
Journal of the National Cancer Institute|November 19, 2024
Obesity-specific improvement of lung cancer outcomes and immunotherapy efficacy with metforminRandall J Smith, Robert Zollo, Sukumar Kalvapudi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Thoracic Disease|June 16, 2023
Obesity and lung cancer-a narrative reviewYeshwanth Vedire, Sukumar Kalvapudi, Sai Yendamuri
Frontiers in Oncology|December 25, 2023
Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challengesSukumar Kalvapudi, Yeshwanth Vedire, Sai Yendamuri, et al.
Healthcare (Basel, Switzerland)|March 11, 2023
Geographical Disparities in Esophageal Cancer Incidence and Mortality in the United StatesYeshwanth Vedire, Navpreet Rana, Adrienne Groman, et al.
BMC Cancer|August 19, 2023
Skeletal muscle index is associated with long term outcomes after lobectomy for non-small cell lung cancerYeshwanth Vedire, Lindsay Nitsche, Madeline Tiadjeri, et al.
Cancers|July 27, 2022
Visceral Obesity in Non-Small Cell Lung CancerLindsay Nitsche, Yeshwanth Vedire, Eric Kannisto, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 17, 2024
Sex-based differences in the lung immune microenvironment are associated with an increased risk of lung cancer in womenRandall Smith, Kaylan N Gee, Sukumar Kalvapudi, et al.
Annals of Thoracic Surgery Short Reports|December 17, 2024
Sex-Specific Effects of Body Composition on Tumor Microenvironment in Non-Small Cell Lung Cancer: Obesity, Gender, and TME in NSCLCYeshwanth Vedire, Robert Seager, Erik Van Roey, et al.
ERJ Open Research|June 21, 2023
Immunoprofiling bronchoalveolar lavage cells reveals multifaceted smoking-associated immune dysfunctionRandall Smith, Sai Yendamuri, Yeshwanth Vedire, et al.
JCI Insight|August 26, 2025
Glucagon-like peptide-1 receptor agonism improves lung cancer outcomes and tumor growth controlAkhil Goud Pachimatla, Bailey Fitzgerald, Joyce Ogidigo, et al.
Journal of the National Cancer Institute|November 19, 2024
Obesity-specific improvement of lung cancer outcomes and immunotherapy efficacy with metforminRandall J Smith, Robert Zollo, Sukumar Kalvapudi, et al.
Pageof 1